相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Relationship between serum tumor markers and Anaplastic Lymphoma Kinase mutations in stage IV lung adenocarcinoma in Hubei province, Central China
Qi Tan et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)
Distribution of serum neuron-specific enolase and the establishment of a population reference interval in healthy adults
Qian Liu et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2019)
Correction of serum NSE reference intervals includes the unidentified hemolysis sample: 1-year data analysis from healthcare individuals
Erfu Xie et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2019)
To report or not to report: a proposal on how to deal with altered test results in hemolytic samples
Janne Cadamuro et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
Reporting altered test results in hemolyzed samples: is the cure worse than the disease?
Giuseppe Lippi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
Validation of Hemolysis Index Thresholds Optimizes Detection of Clinically Significant Hemolysis
Tanu Goyal et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
Harmonization of automated hemolysis index assessment and use: Is it possible?
Alberto Dolci et al.
CLINICA CHIMICA ACTA (2014)
Individualized correction of neuron-specific enolase (NSE) measurement in hemolyzed serum samples
Nicole V. Tolan et al.
CLINICA CHIMICA ACTA (2013)
Can the Roche hemolysis index be used for automated determination of cell-free hemoglobin? A comparison to photometric assays
Darinka Todorova Petrova et al.
CLINICAL BIOCHEMISTRY (2013)
Continuous-Flow Automation and Hemolysis Index: A Crucial Combination
Giuseppe Lippi et al.
JALA (2013)
Short-term prognostic value of serum neuron specific enolase and S100B in acute stroke patients
Sergio Gonzalez-Garcia et al.
CLINICAL BIOCHEMISTRY (2012)
Neuron-Specific Enolase, S100B, and Glial Fibrillary Acidic Protein Levels as Outcome Predictors in Patients With Severe Traumatic Brain Injury
Ana Elisa Boehmer et al.
NEUROSURGERY (2011)
Hemolysis correction factor in the measurement of serum neuron-specific enolase
Charlotte J. Verfaillie et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
Haemolysis index - an estimate of preanalytical quality in primary health care
John Soderberg et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
Comparison of visual vs. automated detection of lipemic, icteric and hemolyzed specimens: can we rely on a human eye?
Ana-Maria Simundic et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
Multicenter evaluation of the hemolysis index in automated clinical chemistry systems
Giuseppe Lippi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
Survey on the prevalence of hemolytic specimens in an academic hospital according to collection facility: opportunities for quality improvement
Giuseppe Lippi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
Derivation and validation of an equation for adjustment of neuron-specific enolase concentrations in hemolyzed serum
Rachel Berger et al.
PEDIATRIC CRITICAL CARE MEDICINE (2009)
Risk management in the preanalytical phase of laboratory testing
Giuseppe Lippi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2007)
The use of serum biomarkers to predict outcome after traumatic brain injury in adults and children
Rachel Pardes Berger
JOURNAL OF HEAD TRAUMA REHABILITATION (2006)
Preanalytical variability: the dark side of the moon in laboratory testing
G Lippi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice
L Ramont et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2005)
ProGRP:: a new biomarker for small cell lung cancer
R Molina et al.
CLINICAL BIOCHEMISTRY (2004)
Technical performance and diagnostic utility of the new Elecsys (R) neuron-specific enolase enzyme immunoassay
T Muley et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2003)
Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease
AJ Aksamit et al.
NEUROLOGY (2001)
Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease
AJE Green et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)